Corda Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Buy
272,363
+8,786
+3% +$842K 1.63% 28
2025
Q4
$25.3M Buy
263,577
+2,324
+0.9% +$226K 1.84% 26
2025
Q3
$24.9M Buy
261,253
+195
+0.1% +$17.9K 1.75% 26
2025
Q2
$22.8M Buy
261,058
+9,551
+4% +$810K 1.67% 30
2025
Q1
$22.6M Buy
251,507
+2,236
+0.9% +$200K 1.8% 29
2024
Q4
$19.9M Buy
249,271
+7,386
+3% +$639K 1.59% 32
2024
Q3
$21.8M Buy
241,885
+6,921
+3% +$582K 1.7% 30
2024
Q2
$18.5M Buy
234,964
+7,204
+3% +$591K 1.5% 32
2024
Q1
$19.8M Buy
227,760
+14,023
+7% +$1.2M 1.58% 32
2023
Q4
$17.6M Buy
213,737
+1,371
+0.6% +$104K 1.48% 32
2023
Q3
$16.6M Buy
212,366
+7,779
+4% +$651K 1.51% 33
2023
Q2
$18M Buy
204,587
+10,788
+6% +$929K 1.41% 37
2023
Q1
$15.6M Buy
193,799
+28,403
+17% +$2.31M 1.25% 37
2022
Q4
$12.9M Buy
165,396
+12,003
+8% +$973K 1.05% 41
2022
Q3
$12.4M Buy
+153,393
New +$13.8M 1.11% 38

Other funds holding MDT

Corda Investment Management's MDT Position: Q1 2026 in Review

Corda Investment Management increased its Medtronic (MDT) stake by 3.3% in Q1 2026, buying an estimated $842K and bringing the position to 272,363 shares worth $23.6M. The position accounts for 1.63% of the portfolio, ranked #28.

Corda Investment Management first reported a position in MDT in Q3 2022 and has held it in 15 quarters since. The position peaked at $25.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Corda Investment Management held 272,363 shares of Medtronic worth $23.6M as of Q1 2026.
  • Corda Investment Management bought 8,786 Medtronic shares in Q1 2026, an estimated $842K.
  • Medtronic made up 1.63% of Corda Investment Management's portfolio in Q1 2026, its #28 holding.
  • Corda Investment Management first reported a position in Medtronic in Q3 2022 and has held it in 15 quarters since.
  • Corda Investment Management's Medtronic position peaked at $25.3M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Corda Investment Management's 13F filing for Q1 2026, filed 4 May 2026.